Drugs in Context

Aims & Scope

Drugs in Context is an open access, peer-reviewed, continuous publication of international standing.

It is listed on PubMed and free-to-view/download on PubMed Central.

Primarily publishes high-quality, peer-reviewed original research papers and topical review articles covering the latest evidence and innovations in drug treatment across all therapeutic areas.

Covers all phases of original research: laboratory, animal and human/clinical studies, health economics and outcomes research, and postmarketing studies.

Original research that shows positive or negative results are welcomed.

Review articles may cover single-drug reviews, drug class reviews, latest advances in drug therapy, therapeutic-area reviews, place-in-therapy reviews, new pathways and classes of drugs.

In addition, systematic reviews and meta-analyses are welcomed and may be published as original research if performed per accepted guidelines.

Editorials of key topics and issues in drugs and therapeutics are welcomed.

We will also consider manuscripts of interest in areas such as technologies that support diagnosis, assessment and treatment.

EQUATOR Network reporting guidelines should be followed for each article type.

GPP3 Guidelines should be followed for any industry-sponsored manuscripts.

Other Editorial sections may include Editorial, Case Report, Conference Report, Letter-to-the-Editor, Educational Section.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)
• Embase

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology, Medicine and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Preservation url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.